Frontline plc.
20.2.2026 12:50:05 CET | Globenewswire | Press release
FRO – Invitation to Q4 2025 Results Conference Call and Webcast
FRO – Invitation to Q4 2025 Results Conference Call and Webcast
Frontline plc.’s preliminary fourth quarter 2025 results will be released on Friday February 27, 2026, and a webcast and conference call will be held at 3:00 p.m. CET (9:00 a.m. U.S. Eastern Time). The results presentation will be available for download from the Investor Relations section at www.frontlineplc.cy ahead of the conference call.
In order to attend the conference call you may do one of the following:
a. Webcast
Go to the Investor Relations section at www.frontlineplc.cy and follow the “Webcast” link, or access directly from the link below.
b. Conference Call
Participants will need to register online prior to the conference call via the link below. Dial-in details will be available when registered.
Frontline plc Q4 2025 Conference Call
A Q&A session will be held after the teleconference/webcast. Information on how to submit questions will be given at the beginning of the session.
The presentation material which will be used in the teleconference/webcast can be downloaded from www.frontlineplc.cy
This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Trifork Group AG26.8.2026 17:43:32 CEST | Press release
51/2026・Trifork Group: Reporting of transactions made by persons discharging managerial responsibilities
Scandinavian Tobacco Group A/S26.8.2026 17:20:00 CEST | Press release
Scandinavian Tobacco Group: Interim Report 1 January – 30 June 2026: Progressing with Focus2030 and Full Year 2026 Guidance maintained
Aegon Ltd.26.8.2026 15:50:00 CEST | Press release
Aegon has filed Shareholder Circular for proposed US redomiciliation
ODDIFACT26.8.2026 15:27:59 CEST | Press release
Oddifact and Mabion Receive FDA Pre-IND Meeting Grant for RTX-NP (MabionCD20) in Immune Thrombocytopenia
Værdipapirfonden Independent Invest II26.8.2026 15:03:40 CEST | Pressemeddelelse
Fusion af afdelinger i Værdipapirfonden Independent Invest II
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom